[E-Daily Reporter NA EUN-KYUNG ] BukwangPharmaceutical(003000)announced on the 11th that it was selected as a “2026 Korea’s Top Job-Creating Company” by the Ministry of Employment and Labor and received a certificate of recognition in the name of the President on the 10th.
BukwangPharmaceutical CEO Lee Je-young (right) poses for a commemorative photo after receiving a certificate from Minister of Employment and Labor Kim Young-hoon at the “2026 Korea’s Top Job Creation Companies” certification ceremony held on the 10th at the Peace & Park Convention Center in Yongsan-gu, Seoul. (Photo courtesy of BukwangPharmaceutical)
The “Korea’s Top Job Creation Companies” program selects companies through a comprehensive evaluation of their efforts to improve job quality—including job creation, improvement of working conditions, work-life balance, and employment stability—with 100 companies nationwide selected this year. Selected companies receive various benefits, such as preferential loan interest rates and credit ratings from financial institutions, bonus points in government procurement, and priority funding for the purchase of facilities and equipment to prevent workplace accidents.
BukwangPharmaceutical was selected as a “Top Job Creation Company in Korea” this year, receiving high praise for operating various programs that support work-life balance for its employees.
Having introduced a flexible work schedule system in 2024 that allows employees to choose their start times based on individual circumstances, BukwangPharmaceutical established a time-based annual leave system last year, enabling employees to freely take time off as needed.
BukwangPharmaceutical explains that this allows employees to respond more flexibly to various situations that arise in daily life, such as medical appointments or childcare. It is also fostering a work environment that supports work-life balance by enhancing the convenience of taking leave and increasing job satisfaction among employees.
BukwangPharmaceutical is also strengthening its programs to encourage long-term service. For example, it has expanded its long-service award system by adding 5- and 15-year milestones to the existing 10- and 20-year awards, creating a structure that recognizes service in five-year increments.
A BukwangPharmaceutical spokesperson stated, “It is important to create a work environment where employees can focus on their work in a stable setting and harmoniously balance their work and personal lives,” adding, “We will continue to improve our systems in ways that employees can truly feel, and we will foster an organizational culture that allows us to grow together in the long term.”
The Financial Supervisory Service (FSS) has launched a surprise on-site investigation into the three major domestic credit rating agencies in connection with the series of defaults by JR GLOBAL REIT a…
SamilPharmaceutical(000520)With “Lorecivivint,” a new drug for osteoarthritis for which BioSplice holds exclusive domestic distribution rights, entering the regulatory review process in the UK followi…
BukwangPharmaceutical(003000)announced on the 11th that it was selected as a “2026 Korea’s Top Job-Creating Company” by the Ministry of Employment and Labor and received a certificate of recognition i…